Press Releases Bicycle Therapeutics plc

Equities

BCYC

US0887861088

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-07 EDT			5-day change	1st Jan Change
23.08 ^USD	-0.94%		-1.58%	+27.65%

05-06	European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading	MT
05-02	European Equities Traded in the US as American Depositary Receipts Rise Modestly Higher in Thursday Trading	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bicycle Therapeutics : May 2024 Corporate Deck	05-06	PU
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results	05-02	BU
Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting	04-24	BU
Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference	04-02	BU
Bicycle Therapeutics to Present at the AACR Annual Meeting 2024	03-05	BU
Bicycle Therapeutics to Participate in Upcoming Investor Conferences	02-28	BU
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results	02-20	BU
Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference	02-07	BU
Bicycle Therapeutics : 2023 R&D Day Deck	12-14	PU
Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day	12-14	BU
IMUNON Appoints Dr. Sebastien Hazard as Chief Medical Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	12-11	AQ
Bicycle Therapeutics to Host R&D Day on December 14	11-30	BU
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming R&D Day	11-02	BU
Bicycle Therapeutics to Participate in Upcoming Investor Conferences	23-10-30	BU
Bicycle Therapeutics Selected to Participate in FDA Program to Expedite Commercial Manufacturing Readiness of BT8009 for Metastatic Bladder Cancer	23-10-19	BU
Macomics Announces the Appointment of Kevin Lee as Independent Non-Executive Director	23-10-19	AQ
Bicycle Therapeutics : BT8009 Regulatory Update \| Bicycle Therapeutics	23-09-11	PU
Bicycle Therapeutics Announces Expedited Development Plan for BT8009 in Metastatic Bladder Cancer	23-09-11	BU
Bicycle Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference	23-09-05	BU
Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update	23-08-03	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Bicycle Therapeutics plc

Equities

BCYC

US0887861088

Press Releases

Filters